Return to homepagePandemic Pact

Development of mucosal-administered nucleic acid vaccine based on pharmaceutics and immunology-Covid-19 prevention-

Grant number: 21H02648

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2024

  • Known Financial Commitments (USD)

    $155,610

  • Funder

    KAKENHI

  • Principal Investigator

    Hitoshi Sasaki Unspecified

  • Research Location

    Japan

  • Lead Research Institution

    Nagasaki University

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract